Download PDF
Thromb Haemost 2014; 112(03): 624-626
DOI: 10.1160/TH13-11-0936
Letters to the Editor
Schattauer GmbH

Impact of heparin-induced thrombocytopenia on acute coronary artery thrombosis in patients undergoing PCI

Takuma Maeda
1   Division of Transfusion Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan
,
Teruo Noguchi
2   Department of Cardiology, National Cerebral and Cardiovascular Center, Osaka, Japan
,
Shin Saito
3   Department of Cardiology, Hirosaki University School of Medicine and Hospital, Aomori, Japan
,
Rei Yoshioka
4   Department of Cardiology, Yanagawa Hospital, Fukuoka, Japan
,
Eishun Horibe
5   Department of Cardiology, Japanese Red Cross Takayama Hospital, Gifu, Japan
,
Sunao Miyanaga
6   Department of Cardiology, Sendai Medical Association Hospital, Kagoshima, Japan
,
Shu Seguchi
1   Division of Transfusion Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan
,
Yoshiaki Kanaumi
1   Division of Transfusion Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan
,
Takeshi Kawai
1   Division of Transfusion Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan
,
Hitoshi Okazaki
7   Department of Transfusion Medicine, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan
,
Shigeki Miyata
1   Division of Transfusion Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan
› Author Affiliations Financial support:This research was supported by a Health and Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare of Japan and Intramural Research Fund (22–1–1) for Cardiovascular Disease of the National Cerebral and Cardiovascular Center.
Further Information

Publication History

Received: 14 November 2013

Accepted after major revision: 24 April 2014

Publication Date:
20 November 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 McEntegart MB, Kirtane AJ, Cristea E. et al. Intra-procedural thrombotic events during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes are associated with adverse outcomes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol 2012; 59: 1745-1751.
    CrossrefPubMedGoogle Scholar
  • 2 Brieger DB, Mak KH, Kottke-Marchant K. et al. Heparin-induced thrombocytopenia. J Am Coll Cardiol 1998; 31: 1449-1459.
    CrossrefPubMedGoogle Scholar
  • 3 Lee DH, Warkentin TE, Denomme GA. et al. A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry. Br J Haematol 1996; 95: 724-731.
    CrossrefPubMedGoogle Scholar
  • 4 Hughes M, Hayward CP, Warkentin TE. et al. Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood 2000; 96: 188-194.
    PubMedGoogle Scholar
  • 5 Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med 2001; 135: 502-506.
    CrossrefPubMedGoogle Scholar
  • 6 Fefer P, Daoulah A, Strauss BH. et al. Visible angiographic complications predict short and long-term outcomes in patients with post-procedural creatine-phosphokinase elevation. Catheter Cardiovasc Interv 2010; 76: 960-966.
    CrossrefPubMedGoogle Scholar
  • 7 Williams RT, Damaraju LV, Mascelli MA. et al. Anti-platelet factor 4/heparin antibodies: an independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes. Circulation 2003; 107: 2307-2312.
    CrossrefPubMedGoogle Scholar
  • 8 Foo SY, Everett BM, Yeh RW. et al. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization. Am Heart J 2006; 152: 290e1-7.
    CrossrefPubMedGoogle Scholar
  • 9 Warkentin TE, Sheppard JA, Moore JC. et al. Studies of the immune response in heparin-induced thrombocytopenia. Blood 2009; 113: 4963-4969.
    CrossrefPubMedGoogle Scholar
  • 10 Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 2001; 344: 1286-1292.
    CrossrefPubMedGoogle Scholar
  • 11 Warkentin TE, Cuker A. Differential diagnosis of heparin-induced thrombocytopenia and scoring system. In Warkentin TE, Greinacher A. eds Heparin-induced thrombocytopenia. 5th ed. CRC press; 2013. p 77-109.
    Google Scholar
  • 12 Kornowski R, Mehran R, Dangas G. et al. Prognostic impact of staged versus "one-time" multi-vessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. J Am Coll Cardiol 2011; 58: 704-711.
    CrossrefPubMedGoogle Scholar
  • 13 Vlaar PJ, Mahmoud KD, Holmes Jr. DR. et al. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis. J Am Coll Cardiol 2011; 58: 692-703.
    CrossrefPubMedGoogle Scholar
  • 14 Mahaffey KW, Lewis BE, Wildermann NM. et al. The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results. J Invasive Cardiol 2003; 15: 611-616.
    PubMedGoogle Scholar
  • 15 Lewis BE, Matthai Jr. WH, Cohen M. et al. Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia. Catheter Cardiovasc Interv 2002; 57: 177-184.
    CrossrefPubMedGoogle Scholar